In 2022, we launched Diabeta, the first conversational AI interface, addressed to diabetologists
Diabeta is approved by ANMDM - National Agency for Medicines and Medical Devices in Romania.
Diabeta was developed for diabetologists, but is now used by doctors in other specialties.
A multidisciplinary team from the medical field, artificial intelligence (natural language processing) and communication worked on developing the chatbot.
Diabeta is supported by globally renowned companies: Novo Nordisk, Boehringer, Medtronic.
About Us
We are a team of Romanian specialists in programming, computational linguistics, and marketing.
We use our own data mining tools and our chatbots are based on artificial intelligence.
We develop intuitive chatbots for healthcare proffesionals to better access medical information.
Now we are busy developing chatbots for various pathologies with a high impact on health.
Contact Us
